z-logo
open-access-imgOpen Access
A Case Study on Multiple Myeloma
Author(s) -
Rakesh Kumar Jha,
Dhruba Hari Chandi
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i37b32032
Subject(s) - multiple myeloma , medicine , bone marrow , anemia , cancer , disease , plasma cell myeloma , plasma cell , pathology
Multiple myeloma (MM), also known as plasma cell myeloma and simply myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Often, no symptoms are noticed initially. As it progresses, bone pain, anemia, kidney dysfunction, and infections may occur. Multiple myeloma is a hematologic disease characterized by an increase in plasma cells in the bone marrow and, more commonly, the presence of monoclonal immunoglobulin in the blood and / or urine. It is the second major hematologic attack found to have an annual occurrence with an increase in the United States of nearly 15,000 and approximately 45,000, respectively. The condition is higher with age (age between acquisitions of 67 yr). This case report describes a multiple myeloma patient presented with muscle sclerosis and was suspected of having myotonic dystrophy type 2 and illustrates the aspects of differential diagnosis, the use of laboratory and imaging for diagnosis. Conclusion: Despite the fact that periodontal illness has a detrimental impact on one's quality of life, those benefits are often ignored. As a consequence, periodontal consultation can be a key component of MM care. Treatment for periodontal disease should begin as soon as possible.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here